Tag Archives: says

Mallinckrodt paid ‘kickbacks’ to keep drug price high, and stuck taxpayers with bill, DOJ lawsuit says

In its complaint, the government demanded a jury trial that would put front and center the actions of the company at the heart of a 97,000% drug price hike. The price of Mallinckrodt’s anti-inflammatory drug Acthar — best known for treating babies with a debilitating seizure disorder — has gone from $ 40 a vial… Read More »

More young people, especially girls, are attempting suicide by poisoning, study says

Researchers at Nationwide Children’s Hospital in Columbus, Ohio, and the Central Ohio Poison Center recorded the number of phone calls made to US poison centers between 2000 and 2018 for self-poisoning of children and young adults ages 10 to 24 that were believed to be suicide attempts. Over the 19-year study period, there were 1.6… Read More »

Providers looking to reduce costs need to address the social determinants, Humana says

Providers striving to generate better health outcomes and reduce costs should increasingly help patients address social and economic concerns–such as isolation and food insecurity–along with their physical conditions. That’s one of the key takeaways of Humana’s new 2019 Bold Goals Progress Report, which examines the company’s own progress in improving results among some of its… Read More »